BPC-157
Synthetic pentadecapeptide derived from a gastric protective protein sequence. Widely referenced in preclinical cytoprotection and angiogenesis literature.
What the literature says.
Mechanism of action
Literature describes activation of VEGFR2 and downstream Akt/eNOS signaling, promoting endothelial proliferation and angiogenesis in injured tissue models. Effects on nitric oxide, dopamine, and serotonin systems have also been reported in rodent studies.
Preclinical summary
BPC-157 is a 15-amino-acid synthetic peptide studied in preclinical models of gastrointestinal injury, tendon repair, and vascular remodeling. Research interest centers on the VEGFR2–Akt–eNOS signaling axis.
Safety
Research material only. Not a drug, supplement, or food product. No human or animal administration is supported or implied. Handling should follow the purchaser's institutional biosafety and chemical hygiene protocols.
Shipping & storage
Ships overnight in insulated packaging with ice packs when lab conditions require. Store lyophilized powder at 2–8°C. After reconstitution, store at 2–8°C and use within standard stability windows documented on the lot-specific Certificate of Analysis.
The compound, in numbers.
Research use only.
These products are intended for laboratory research purposes only and are not for human or animal consumption.
The statements on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
